Circulate Health, a leader in precision Therapeutic Plasma Exchange (TPE) technologies and microplastics technologies, announces a strategic investment from Scrum Ventures, a global early-stage venture capital firm known for its strong focus on sports, human performance, and next-generation health technologies. The seven-figure investment will accelerate Circulate's ongoing growth.